Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: Estrone sulfate |
Click to Show/Hide the Full List of HOSPPI: 4 HOSPPI
|
Cytochrome P450 1A2 (CYP1A2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0003
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP1A2-sulF interaction |
[1], [2] |
Description |
The interaction, between human Cytochrome P450 1A2 and Sulfatase from Parabacteroides johnsonii which collectively metabolize the drug Estrone sulfate, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 2C9 (CYP2C9) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0019
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2C9-sulF interaction |
[1], [3] |
Description |
The interaction, between human Cytochrome P450 2C9 and Sulfatase from Parabacteroides johnsonii which collectively metabolize the drug Estrone sulfate, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cytochrome P450 3A4 (CYP3A4) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0001
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP3A4-sulF interaction |
[1], [4] |
Description |
The interaction, between human Cytochrome P450 3A4 and Sulfatase from Parabacteroides johnsonii which collectively metabolize the drug Estrone sulfate, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Tyrosine-protein phosphatase STS1/TULA2 (UBASH3B) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0430
DME Info
|
Uniprot ID |
|
Interaction Name |
UBASH3B-sulF interaction |
[1], [5] |
Description |
The interaction, between human Tyrosine-protein phosphatase STS1/TULA2 and Sulfatase from Parabacteroides johnsonii which collectively metabolize the drug Estrone sulfate, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|